Skip to main content

Pralsetinib



General

Brand Names: U.S.

  • Gavreto

Indications

Use: Labeled Indications

Non-small cell lung cancer, metastatic RET fusion-positive: Treatment of metastatic RET fusion-positive non-small cell lung cancer (N...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

×